Opendata, web and dolomites

Horizon2020 projects coordinated by "INDEX PHARMACEUTICALS AB"

# project acronym  year  total cost  totalcontribution 
1 UCRXF A novel ulcerative colitis treatment - A phase III ready feasibility study 2018 71˙429.00 50˙000.00